Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2018 Nov 29;93(6):1048–1056. doi: 10.1002/ccd.27958

Table 3.

IVUS Findings in Successfully Recanalized CTO Lesions

Intraplaque Tracking (n = 73) Subintimal Tracking (n = 84) p Value
Total Stent Length, mm 46.1 [31.9, 58.7] 74.1 [55.7, 86.8] <0.0001
Subintimal Length, mm 17.4 [8.2, 34.6]
    >10 mm 39 (46.4)
MSA in entire stent length, mm2 5.5 [4.1, 7.3] 4.8 [3.8, 6.01] 0.03
MSA < 5 mm2 entire stent length 31/70 (44.3) 33/62 (53.2) 0.30
MSA in CTO segment, mm2 6.1 [4.9–8.3] 6.2 [5.1–6.9] 0.31
MSA <5 mm2 in CTO segment 22 (30.1) 37 (44.1) 0.07
IVUS-VI * 35 (48.9) 77 (91.7) <0.0001
    Intramural Hematoma 13 (17.8) 48 (57.1) <0.0001
    Perivascular Hematoma 5 (6.9) 30 (35.7) <0.0001
    Total Length Of Hematoma 9.0 [5.2,12.3] 14.0 [6.8, 22.3] 0.07
    Perivascular Blood Speckle 29 (39.7) 66 (78.7) <0.0001
Malapposition 12 (17.1) 10 (16.1) 0.88
    Significant 8 (11.4) 4 (6.5) 0.38
Tissue Protrusion 5 (7.1) 10 (16.1) 0.17
    Significant 3 (4.3) 5 (8.1) 0.47
Stent Edge Dissection 6 (8.2) 11 (13.1) 0.33
    Significant§ 3 (4.3) 5 (8.1) 0.47

Continuous values are reported as mean ± (standard deviation) or median [interquartile range]

*

IVUS-VI includes any of the following: intramedial hematoma, perivascular hematoma, perivascular blood speckle.

Malapposition area >10% lumen area.

Protruded tissue area >10% stent area.

§

Dissection >3 mm in length and >60° in angle.

MSA - minimum stent area, CTO- chronic total occlusion, IVUS-VI – intravascular ultrasound vascular injury